Judge deems antitrust suit to be outside arbitration

A federal district court has ruled Johnson & Johnson and Janssen Biotech cannot force individual arbitration of antitrust claims brought by a class of direct purchasers of Remicade.

Get unlimited access to all Global Competition Review content